Staphylococcus aureus Small-Colony Variants from Airways of Adult Cystic Fibrosis Patients as Precursors of Adaptive Antibiotic-Resistant Mutations
Antibiotics · 17.06.2023 · 12 (6) · 1069
DOI: 10.3390/antibiotics12061069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 17.06.2023. Verfasst von Guillaume Millette und 7 weiteren Autor:innen. Beteiligte Einrichtung: Département de Biologie, Faculté des Sciences, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cystic Fibrosis Canada, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Prototypic Staphylococcus aureus and their small-colony variants (SCVs) are predominant in cystic fibrosis (CF), but the interdependence of these phenotypes is poorly understood. We characterized S. aureus isolates from adult CF patients over several years. Of 18 S. aureus-positive patients (58%), 13 (72%) were positive for SCVs. Characterization included genotyping, SCCmec types, auxotrophy, biofilm production, antibiotic susceptibilities and tolerance, and resistance acquisition rates. Whole-genome sequencing revealed that several patients were colonized with prototypical and SCV-related clones. Some clonal pairs showed acquisition of aminoglycoside resistance that was not explained by aminoglycoside-modifying enzymes, suggesting a mutation-based process. The characteristics of SCVs that could play a role in resistance acquisition were thus investigated further. For instance, SCV isolates produced more biofilm (p < 0.05) and showed a higher survival rate upon exposure to ciprofloxacin and vancomycin compared to their prototypic associated clones. SCVs also developed spontaneous rifampicin resistance mutations at a higher frequency. Accordingly, a laboratory-derived SCV (ΔhemB) acquired resistance to ciprofloxacin and gentamicin faster than its parent counterpart after serial passages in the presence of sub-inhibitory concentrations of antibiotics. These results suggest a role for SCVs in the establishment of persistent antibiotic-resistant clones in adult CF patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Département de Biologie, Faculté des Sciences, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.
- Service de Pneumologie, Département de Médecine, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
ORCID-Profile: Guillaume Millette, François Malouin
Förderung
- Cystic Fibrosis Canada
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Millette, G., Séguin, D. L., Isabelle, C., Chamberland, S., Lucier, J. F., Rodrigue, S., Cantin, A. M., & Malouin, F. (2023). Staphylococcus aureus Small-Colony Variants from Airways of Adult Cystic Fibrosis Patients as Precursors of Adaptive Antibiotic-Resistant Mutations. Antibiotics, 12(6), 1069. https://doi.org/10.3390/antibiotics12061069
Vancouver
Millette G, Séguin DL, Isabelle C, Chamberland S, Lucier JF, Rodrigue S, et al. Staphylococcus aureus Small-Colony Variants from Airways of Adult Cystic Fibrosis Patients as Precursors of Adaptive Antibiotic-Resistant Mutations. Antibiotics. 2023;12(6):1069. doi:10.3390/antibiotics12061069
BibTeX
@article{Millette2023,
author = {Millette, Guillaume and Séguin, David Lalonde and Isabelle, Charles and Chamberland, Suzanne and Lucier, Jean-François and Rodrigue, Sébastien and Cantin, André M and Malouin, François},
title = {Staphylococcus aureus Small-Colony Variants from Airways of Adult Cystic Fibrosis Patients as Precursors of Adaptive Antibiotic-Resistant Mutations},
journal = {Antibiotics},
year = {2023},
volume = {12},
number = {6},
pages = {1069},
doi = {10.3390/antibiotics12061069}
}
EUVIMED